NCI and Cancer Research UK awarded $125 million in total funding through the Cancer Grand Challenges program, supporting research on cancer inequities, early-onset cancers, solid tumors in children, and T-cell receptors. The $125 million investment marks the Cancer Grand Challenges program’s largest funding round to date.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
